SGMT

Sagimet Biosciences Inc. SGMT

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $2.0M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Top Institutional Holders

as of Q2 2026
$394.28M total
BlackRock, Inc.
$50.83M+722.0%
BALYASNY ASSET MANAGEMENT L.P.
$28.03MNew
Woodline Partners LP
$23.20M+199.8%
SILVERARC CAPITAL MANAGEMENT, LLC
$22.63MNew
VANGUARD CAPITAL MANAGEMENT LLC
$19.84M+133.5%
BVF INC/IL
$19.32MNew
Caligan Partners LP
$19.32MNew
Affinity Asset Advisors, LLC
$19.31M+187.8%
FEDERATED HERMES, INC.
$16.13MNew
GREAT POINT PARTNERS LLC
$15.69MNew
STATE STREET CORP
$15.42M+1449.1%
Saturn V Capital Management LP
$11.44MNew
GEODE CAPITAL MANAGEMENT, LLC
$11.17M+366.5%
Blue Owl Capital Holdings LP
$9.74M+277.5%
BAKER BROS. ADVISORS LP
$7.37M0.0%
MILLENNIUM MANAGEMENT LLC
$7.24M+8.7%
abrdn plc
$6.55MNew
GOLDMAN SACHS GROUP INC
$5.87M+348.5%
Hillhouse Capital Advisors, Ltd.
$5.60M0.0%
AMERIPRISE FINANCIAL INC
$4.49MNew
Vestal Point Capital, LP
$4.14MNew
NORTHERN TRUST CORP
$3.62M+743.8%
BOOTHBAY FUND MANAGEMENT, LLC
$3.59MNew
ADAR1 Capital Management, LLC
$3.38MNew
FARALLON CAPITAL MANAGEMENT LLC
$3.21MNew
See all 122 institutional holders →
Reading the latest SEC filing…

Key Metrics

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

ROIC

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/SGMT

Earnings Per Share

13fpro.ai/company/SGMT

Loading ratio trend…

SGMT key financials by period

Reported revenue, net income and operating margin by fiscal year, from Sagimet Biosciences Inc.'s annual filings on SEC EDGAR.

Sagimet Biosciences Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2023$2.0M$-27.9M—
Source: SGMT filings on SEC EDGAR →

SGMT insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About Sagimet Biosciences Inc. (SGMT): stock profile, AI score and financials

Sagimet Biosciences Inc. (SGMT) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. SGMT is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $2.0m in revenue and is scored on the micro-cap board instead. Top institutional holders of SGMT by reported 13-F value include BlackRock, BALYASNY ASSET MANAGEMENT L.P., Woodline Partners, based on the most recent SEC filings. SGMT trades on the Nasdaq exchange and files with the SEC under CIK 1400118. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate SGMT daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Sagimet Biosciences Inc. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1400118 →